AVTR 10-Q Quarterly Report Sept. 30, 2025 | Alphaminr
Screener Snapshot View

AVTR 10-Q Quarter
ended Sept. 30, 2025


Finance Dashboard
Avantor, Inc. - AVTR
$10.93
-0.22 (-1.97%)
Market Cap
$7,452,236,409
Enterprise Value
$11,055,436,409
Average Volume
$10,378,720

Valuation & Solvency

P/Tangible Book
1.34
P/E
-90.64
P/S
1.13
EV/EBITDA
17.15
EV/Sales
1.68
EV/FCF
21.11
Dividend Yield
0.00%
Payout Ratio
0.00%
Total Debt
$3,857,900,000
Cash & Marketable Securities
$251,900,000
Quick Ratio
0.96
Debt/Equity
0.69
Net Debt/EBITDA
5.59
Interest Coverage Ratio
1.52

About

Industry
Medical - Instruments & Supplies
Exchange
NYSE
Country
US
Beta
0.93

Company Description

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.